Pfizer (PFE) Tops Q1 EPS by 2c, Revenues Miss; Reaffirmed Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/4/2026
- Equities close higher as softer jobs data quiets rate-hike expectations
- U.S. economy adds fewer jobs than expected as unemployment rate ticks higher
- Nvidia returns as Morgan Stanley’s Top Pick on attractive valuation
- Citi says rate volatility without Fed repricing is concerning
- U.S. credit-reporting stocks fall as FHFA weighs two-bureau mortgage rule
- Equities close higher as softer jobs data quiets rate-hike expectations
- Cantor Fitzgerald on Rivian (RIVN): 'pre-announced that it delivered 19,248 vehicles in 3Q26, above our estimate'
- DISH DBS emerges from bankruptcy, cuts debt by $4.35 billion
- Tanker struck by projectile in Strait of Hormuz
- AppLovin shares fall after court denies request against Unity
PFIZER REPORTS FIRST-QUARTER 2018 RESULTS
May 1, 2018 6:45 AM EDTFirst-Quarter 2018 Revenues of $12.9 Billion First-Quarter 2018 Reported Diluted EPS(1) of $0.59, Adjusted Diluted EPS(2) of $0.77 Reaffirmed All Components of 2018 Financial Guidance
NEW YORK--(BUSINESS WIRE)-- Pfizer Inc. (NYSE: PFE) reported financial results for first-quarter 2018 and reaffirmed all components of 2018 financial guidance.
Results for the first quarter of 2018 and 2017(3) are summarized below.
OVERALL RESULTS Â($ in millions, except per share amounts)
 First-Quarter 2018   2017   Change Revenues  $  12,906    $  12,779    1% Reported Net Income(1) 3,561 3,121 14% Reported Diluted EPS(1) 0.59 0.51 15% Adjusted Income(2) 4,668 4,192 11% Adjusted Diluted EPS(2) 0.77 0.69 12% ÂREVENUES
 ... More